NZ516100A - Streptogramin derivatives, preparation and compositions containing them - Google Patents

Streptogramin derivatives, preparation and compositions containing them

Info

Publication number
NZ516100A
NZ516100A NZ516100A NZ51610000A NZ516100A NZ 516100 A NZ516100 A NZ 516100A NZ 516100 A NZ516100 A NZ 516100A NZ 51610000 A NZ51610000 A NZ 51610000A NZ 516100 A NZ516100 A NZ 516100A
Authority
NZ
New Zealand
Prior art keywords
preparation
compositions containing
streptogramin derivatives
hydrogen
streptogramin
Prior art date
Application number
NZ516100A
Inventor
Daniel Achard
Eric Bacque
Jean-Claude Barriere
Jean Bouquerel
Pascal Desmazeau
Serge Grisoni
Jean-Pierre Leconte
Yves Ribeill
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ516100(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NZ516100A publication Critical patent/NZ516100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

A group A streptogramin derivative or a pharmaceutically acceptable salt thereof has the formula (I) wherein: R1 is halogen, azido or thiocyanato; R2 is hydrogen, methyl or ethyl and R3 is hydrogen or a residue of an optionally substituted aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic or heterocyclyl-aliphatic ester. The compounds are useful as antibacterial agents.
NZ516100A 1999-06-30 2000-06-29 Streptogramin derivatives, preparation and compositions containing them NZ516100A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908375A FR2795733B1 (en) 1999-06-30 1999-06-30 STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
PCT/FR2000/001818 WO2001002427A1 (en) 1999-06-30 2000-06-29 Streptogramin derivatives, preparation and compositions containing them

Publications (1)

Publication Number Publication Date
NZ516100A true NZ516100A (en) 2004-01-30

Family

ID=9547496

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ516100A NZ516100A (en) 1999-06-30 2000-06-29 Streptogramin derivatives, preparation and compositions containing them

Country Status (37)

Country Link
US (2) US6569854B1 (en)
EP (1) EP1187847B1 (en)
JP (1) JP4585728B2 (en)
KR (1) KR100742035B1 (en)
CN (2) CN1961878A (en)
AP (1) AP1392A (en)
AR (2) AR029758A1 (en)
AT (1) ATE255592T1 (en)
AU (1) AU781923B2 (en)
BG (1) BG65786B1 (en)
BR (1) BRPI0012032B1 (en)
CA (1) CA2376698C (en)
CZ (1) CZ301048B6 (en)
DE (1) DE60006958T2 (en)
DK (1) DK1187847T3 (en)
EA (1) EA005199B1 (en)
EE (1) EE04683B1 (en)
ES (1) ES2207535T3 (en)
FR (1) FR2795733B1 (en)
GE (1) GEP20063972B (en)
HR (1) HRP20010937B1 (en)
HU (1) HUP0201692A3 (en)
IL (2) IL146185A0 (en)
MA (1) MA26802A1 (en)
MX (1) MXPA01012807A (en)
NO (1) NO329456B1 (en)
NZ (1) NZ516100A (en)
OA (1) OA11979A (en)
PT (1) PT1187847E (en)
RS (1) RS50138B (en)
SI (1) SI1187847T1 (en)
SK (1) SK285605B6 (en)
TN (1) TNSN00145A1 (en)
TR (1) TR200103829T2 (en)
UA (1) UA71619C2 (en)
WO (1) WO2001002427A1 (en)
ZA (1) ZA200110150B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775288B1 (en) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2795733B1 (en) * 1999-06-30 2001-09-07 Aventis Pharma Sa STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
US6596717B2 (en) * 2000-12-21 2003-07-22 Aventis Pharma S.A. Streptogramin derivatives, their preparation and compositions which contain them
US7232799B2 (en) 2000-12-21 2007-06-19 Aventis Pharma Sa Streptogramin derivatives and compositions thereof
US7488747B2 (en) 2003-12-29 2009-02-10 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US7565200B2 (en) * 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
CN101394847B (en) 2006-01-06 2017-05-24 塞普拉柯公司 Cycloalkylamines as monoamine reuptake inhibitors
JP5438975B2 (en) 2006-01-06 2014-03-12 サノビオン ファーマシューティカルズ インク Tetralone monoamine reuptake inhibitor
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
JP5420534B2 (en) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク Phenyl-substituted cycloalkylamines as monoamine reuptake inhibitors
CN103508981A (en) * 2012-06-18 2014-01-15 北京美倍他药物研究有限公司 New piperazine derivative and medical applications
CA3070851A1 (en) * 2017-08-01 2019-02-07 The Regents Of The University Of California Methods of making streptogramin compositions and the use thereof
KR102107659B1 (en) 2018-12-07 2020-05-07 경상대학교 산학협력단 Composition for preventing or treating Mycobacterium tuberculosis or nontuberculous mycobacteria infection comprising MMAGNU1 compound
EP4157268A1 (en) 2020-05-27 2023-04-05 Università Degli Studi Di Trento New therapy for the treatment of tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (en) * 1983-07-13 1985-10-25 Rhone Poulenc Sante NOVEL SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2576022B1 (en) * 1985-01-11 1987-09-11 Rhone Poulenc Sante NOVEL DERIVATIVES OF PRISTINAMYCIN II B, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE1001013A4 (en) 1987-10-22 1989-06-13 Icp Internat Inst Of Cellular SYNERGIMYCIN DERIVATIVES OF TYPES A AND B, PROCESS FOR THEIR PREPARATION AND USE THEREOF.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2766489B1 (en) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2795733B1 (en) * 1999-06-30 2001-09-07 Aventis Pharma Sa STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
IL146185A (en) 2007-08-19
CN100543032C (en) 2009-09-23
EA005199B1 (en) 2004-12-30
BRPI0012032B1 (en) 2015-06-30
NO329456B1 (en) 2010-10-25
BG106235A (en) 2002-08-30
DK1187847T3 (en) 2004-01-05
EP1187847B1 (en) 2003-12-03
CZ301048B6 (en) 2009-10-21
ATE255592T1 (en) 2003-12-15
AU6288600A (en) 2001-01-22
GEP20063972B (en) 2006-11-27
YU89501A (en) 2004-05-12
DE60006958T2 (en) 2004-10-21
AP1392A (en) 2005-04-15
RS50138B (en) 2009-03-25
CA2376698C (en) 2013-05-14
NO20016247L (en) 2002-02-08
AP2001002371A0 (en) 2001-12-31
HUP0201692A2 (en) 2002-09-28
WO2001002427A1 (en) 2001-01-11
ZA200110150B (en) 2003-03-10
DE60006958D1 (en) 2004-01-15
EP1187847A1 (en) 2002-03-20
FR2795733A1 (en) 2001-01-05
CN1358194A (en) 2002-07-10
JP4585728B2 (en) 2010-11-24
EE04683B1 (en) 2006-08-15
CA2376698A1 (en) 2001-01-11
US7166594B2 (en) 2007-01-23
US20030149004A1 (en) 2003-08-07
AR066926A2 (en) 2009-09-23
CZ20014641A3 (en) 2002-04-17
BR0012032A (en) 2002-03-19
BG65786B1 (en) 2009-11-30
PL352781A1 (en) 2003-09-08
US6569854B1 (en) 2003-05-27
OA11979A (en) 2006-04-18
MA26802A1 (en) 2004-12-20
TR200103829T2 (en) 2002-04-22
HRP20010937A2 (en) 2003-08-31
CN1961878A (en) 2007-05-16
EA200200108A1 (en) 2002-06-27
HUP0201692A3 (en) 2002-10-28
SK19302001A3 (en) 2002-07-02
KR100742035B1 (en) 2007-07-23
IL146185A0 (en) 2002-07-25
ES2207535T3 (en) 2004-06-01
NO20016247D0 (en) 2001-12-19
HRP20010937B1 (en) 2005-02-28
FR2795733B1 (en) 2001-09-07
SK285605B6 (en) 2007-04-05
AR029758A1 (en) 2003-07-16
KR20020020763A (en) 2002-03-15
JP2003503509A (en) 2003-01-28
TNSN00145A1 (en) 2002-05-30
EE200100706A (en) 2003-04-15
PT1187847E (en) 2004-04-30
SI1187847T1 (en) 2004-04-30
UA71619C2 (en) 2004-12-15
AU781923B2 (en) 2005-06-23
MXPA01012807A (en) 2002-07-22

Similar Documents

Publication Publication Date Title
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
DE60003001D1 (en) Pyrimidinverbindungen
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
IL142649A0 (en) Azole derivatives
MX9602837A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof.
MXPA02012033A (en) 2-aminocarbonyl-9h-purine derivatives.
AU1120599A (en) New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
GB9914486D0 (en) Medicaments
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
HK1052697A1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same.
MX9805023A (en) 1-methylcarbapenem derivatives.
NO983444L (en) Benzo (c) quinolizine derivatives, their preparation and use as 5 <alfa> reductase inhibitors
PL304893A1 (en) Serotoninergic derivatives of ergoline
CA2382654A1 (en) Novel a-500359 derivatives
RO115802B1 (en) Pyrazole dihydrobenzofuranyl propenoic acid derivatives, intermediate for preparing the same, pharmaceutical compositions thereof and method of treatment
ZA981430B (en) Anticancer composition
YU82302A (en) 2-aminocarbonyl-9h-purine derivatives

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: NOVEXEL, FR

Free format text: OLD OWNER(S): AVENTIS PHARMA S.A.

RENW Renewal (renewal fees accepted)
LAPS Patent lapsed